Physical Therapists in Safford, AZ Accepting Medicare

12 Physical Therapists found. Showing 1 - 12

Mrs. La Wynn Brown, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 803 W Navajo Ln, Safford, AZ 85546 Phone: 928-428-0280

Dr. Jace Dobbie Nelson, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2290 W 16th St, Safford, AZ 85546 Phone: 928-348-4220

Jacob E Hansen, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2290 W 16th St, Safford, AZ 85546 Phone: 928-348-4220

Renne Heinrich Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 S 20th Ave Bldg E, Safford, AZ 85546 Phone: 928-651-5359    Fax: 928-348-3868

Jacob Henry Webb, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 S 20th Ave, Bldg E, Safford, AZ 85546 Phone: 928-348-4047

Paul Wayne Nelson, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2290 W 16th St, Safford, AZ 85546 Phone: 928-428-4220

Bart O Judd, P.T., CSCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2290 W 16th St, Safford, AZ 85546 Phone: 928-348-4220    Fax: 928-348-4234

Dr. Max Rodney Allred, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1933 W Pepper Tree Dr, Safford, AZ 85546 Phone: 928-607-9118

Roadrunner Rehab Incorporated Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2290 W 16th St, Safford, AZ 85546 Phone: 928-348-4220    Fax: 928-348-4234

Jesse Bacigalupi, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 S 20th Ave Bldg E, Safford, AZ 85546 Phone: 928-348-4047

The Arbors Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2150 S 1st Ave, Safford, AZ 85546 Phone: 928-348-3293

Tracy Therrien, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 773 E Airport Rd, Safford, AZ 85546 Phone: 800-259-9897

News Archive

Idera begins enrollment in IMO-8400 Phase 2 clinical trial for treatment of dermatomyositis

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing Toll-like receptor (TLR) and RNA therapeutics for patients with cancer and rare diseases, today announced that the company has commenced enrollment in a Phase 2 clinical trial of IMO-8400, an investigational TLR 7, 8 and 9 antagonist, in patients with dermatomyositis. Dermatomyositis is a rare and debilitating inflammatory muscle and skin disease associated with significant morbidity, decreased quality of life and an increased risk of premature death.

Viewpoints: Today's 'personhood' vote in Miss.; reactions to Romney's health care plan

What about in vitro fertilization, a process that both creates and discards embryos? What new rights would be afforded to a fetus, and how would those rights affect or compete with the rights of the woman who carries it? Would a woman who has an abortion be guilty of murder and subject to capital punishment? ... In their quest to ban abortion in Mississippi, the amendment's drafters appear to have rushed past such concerns.

Overview of the important research and treatments in ADHD

Worldwide longitudinal studies performed since the 1970s have clearly shown that ADHD persists into adulthood. These findings have stimulated researchers to develop the therapeutic approaches for adult patients, especially in European countries where scientific and clinical interest in ADHD has increased.

TxCell, LIED collaborate to develop CAR-Treg-based cellular immunotherapy for bullous pemphigoid

TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the Lübeck Institute of Experimental Dermatology, a leading institution in the field of translational research on skin blistering diseases, part of the University of Lübeck in Germany.

Read more Medical News

› Verified 1 days ago